BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30353687)

  • 1. Aberrant CpG-methylation affects genes expression predicting survival in lung adenocarcinoma.
    He W; Ju D; Jie Z; Zhang A; Xing X; Yang Q
    Cancer Med; 2018 Nov; 7(11):5716-5726. PubMed ID: 30353687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.
    Pan X; Ji P; Deng X; Chen L; Wang W; Li Z
    Gene; 2022 Feb; 810():146054. PubMed ID: 34737001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
    Li H; Tong L; Tao H; Liu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
    Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
    Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
    Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
    Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
    Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
    J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
    Dong M; Yang Z; Li X; Zhang Z; Yin A
    Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
    Wang X; Shi D; Zhao D; Hu D
    Biomed Res Int; 2020; 2020():1807089. PubMed ID: 33029490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
    Su Y; Shetty A; Jiang F
    Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
    Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M
    J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.
    Yu Y; Wang Z; Zheng Q; Li J
    Gene; 2021 Jul; 790():145689. PubMed ID: 33964375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhang W; Li T; Hu B; Li H
    Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome‑wide investigation of the clinical significance and prospective molecular mechanisms of kinesin family member genes in patients with lung adenocarcinoma.
    Zhang L; Zhu G; Wang X; Liao X; Huang R; Huang C; Huang P; Zhang J; Wang P
    Oncol Rep; 2019 Sep; 42(3):1017-1034. PubMed ID: 31322267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Expression of
    Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
    DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
    Jung J; Lee YJ; Kim CH; Ahn S
    PLoS One; 2021; 16(3):e0247928. PubMed ID: 33684161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic values of the transcription factor-CpG-gene triplets in lung adenocarcinoma: A narrative review.
    Lian D; Lian L; Zeng D; Zhang M; Chen M; Liu Y; Ying W; Zhou S
    Medicine (Baltimore); 2022 Dec; 101(50):e32045. PubMed ID: 36550923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.